Mashiko Setshedi
Overview
Explore the profile of Mashiko Setshedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1098
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith S, Schulz C, Ugiagbe R, Ndip R, Dieye Y, Leja M, et al.
Dig Dis
. 2024 Mar;
42(3):240-256.
PMID: 38493766
Background: Helicobacter pylori (H. pylori) infection is the most prevalent type of bacterial infection. Current guidelines from different regions of the world neglect specific African conditions and requirements. The African...
2.
Setshedi M, Smith S
Antibiotics (Basel)
. 2023 Jun;
12(6).
PMID: 37370288
() infection is ubiquitous worldwide, with prevalence rates of greater than 70% in Africa. Symptomatic patients present with foregut gastrointestinal symptoms which can be readily diagnosed with standardized non-invasive or...
3.
Sperber A, Bor S, Fang X, Bangdiwala S, Drossman D, Ghoshal U, et al.
Neurogastroenterol Motil
. 2023 Apr;
35(6):e14583.
PMID: 37018412
Background And Aims: The Rome Foundation Global Epidemiology Study (RFGES) assessed the prevalence, burden, and associated factors of Disorders of Gut-Brain Interaction (DGBI) in 33 countries around the world. Achieving...
4.
5.
Setshedi M, Watermeyer G
Front Med (Lausanne)
. 2022 Dec;
9:1013779.
PMID: 36569142
Gastric adenocarcinoma (GCA) is the 5th leading cancer globally with an estimated 1.1 million cases reported in 2020. Ninety percent of non-cardia GCAs are attributable to (), the most prevalent...
6.
Moosa M, Maartens G, Gunter H, Allie S, Chughlay M, Setshedi M, et al.
South Afr J HIV Med
. 2022 Aug;
23(1):1376.
PMID: 35923608
Background: There are limited data on the outcomes of rechallenge with anti-tuberculosis therapy (ATT) following anti-tuberculosis drug-induced liver injury (AT-DILI) in a high HIV prevalence setting. Objectives: To describe the...
7.
Watermeyer G, Awuku Y, Fredericks E, Epstein D, Setshedi M, Devani S, et al.
Lancet Gastroenterol Hepatol
. 2022 Jul;
7(10):962-972.
PMID: 35779534
Inflammatory bowel disease (IBD) is generally considered a disease of high-income countries and is regarded as rare in sub-Saharan Africa. However, this assumption is almost certainly an underestimate, and the...
8.
Watermeyer G, Katsidzira L, Setshedi M, Devani S, Mudombi W, Kassianides C
Lancet Gastroenterol Hepatol
. 2022 Jul;
7(10):952-961.
PMID: 35779533
Over the past century, the incidence of inflammatory bowel disease (IBD) in high-income countries has shown a sharp rise that then plateaued, and a similar trend has been observed in...
9.
Patterson J, Cleary S, Silal S, Hussey G, Enoch A, Korsman S, et al.
BMC Infect Dis
. 2022 Jan;
22(1):45.
PMID: 35016628
Background: While some evidence has been demonstrated the cost-effectiveness of routine hepatitis A vaccination in middle-income countries, the evidence is still limited in other settings including in South Africa. Given...
10.
Parker R, Bedwell G, Hodkinson P, Lourens A, Setshedi M
Afr J Emerg Med
. 2021 Nov;
11(4):483-486.
PMID: 34815928
Pain is one of the most common reasons people present to the emergency centre with 7-10% of presentations being due to acute abdominal pain. However, pain is also often neglected...